HIGHLIGHTS
- who: Chloë De Witte from the The in vivo experimental protocol was approved by the Ethical Committee of the Faculty of Veterinary Medicine, Ghent University, Belgium (EC, have published the article: In-feed bambermycin medication induces anti-inflammatory effects and prevents parietal cell loss without influencing Helicobacter suis colonization in the stomach of mice, in the Journal: (JOURNAL)
- what: The aim of this study was to determine the effect of bambermycin supplementation on the course of a H. suis infection, the host response and the gastric microbiota, as all these parameters may be involved in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.